Candelanza, Juliana N.
HRN: 06-08-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2022
CEFUROXIME 750MG (VIAL)
04/13/2022
04/19/2022
IV
750mg
Q8hours
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Dose
Final appropriateness: Yes
Overall appropriateness: Yes